Skip to main content

Inclusion Body Myositis clinical trials at UC Irvine
1 in progress, 0 open to eligible people

  • Study of Arimoclomol in Inclusion Body Myositis (IBM)

    Sorry, in progress, not accepting new patients

    Funding Source - FDA OOPD. The purpose of this study is to evaluate the safety and efficacy of the study drug, Arimoclomol in IBM patients.

    Irvine, California and other locations

Last updated: